Content Type: International Developments
A Turning Point for Global Health: Integrating Noncommunicable Diseases and Mental Health
Localized Crisis Helplines Integrated into ChatGPT and Sora
ChatGPT and Sora now offer localized crisis helplines, providing immediate, confidential support and ensuring human intervention remains available for those experiencing severe distress.
MHRA and NICE Receive £2 Million from Wellcome to Improve Safety and Effectiveness of Digital Mental Health Technologies
UK regulators MHRA and NICE have received £2 million from Wellcome to strengthen frameworks for the safe, effective, and evidence-based use of digital mental health technologies.
Whakarongorau, New Zealand’s National Telehealth Provider, Advances Mental Health Access With AI Concierge Platform
Whakarongorau, New Zealand’s national telehealth provider, is developing an AI-enabled concierge platform to simplify navigation, enable earlier intervention, and improve equitable access to mental health and addiction support.
Flow Neuroscience tDCS Headset Approved in Australia, Expanding Access to Evidence-Based Depression Treatment
Flow Neuroscience’s tDCS headset for depression has received TGA approval in Australia, providing a safe, at-home, evidence-based treatment option and expanding access to non-medication mental health care.
OpenAI’s Curated Therapist Network Set to Accelerate Global Demand for Mental Health Professionals
OpenAI’s new curated network of therapists, integrated with ChatGPT, could dramatically increase global demand for mental health professionals by providing seamless, immediate access to qualified support.
OpenAI Updates ChatGPT to Improve Handling of Sensitive Mental Health Conversations
OpenAI has updated ChatGPT since August 2025 to improve its handling of sensitive mental health conversations, introducing safeguards for distress, self-harm, psychosis, and emotional reliance, with subsequent updates including GPT‑5.1 maintaining and expanding these safety measures.
FDA Clears Deep TMS™ for Adolescents With Major Depressive Disorder
The FDA has cleared BrainsWay’s Deep TMS™ system as an adjunct treatment for adolescents aged 15–21 with major depressive disorder, expanding access to a noninvasive, evidence-based therapy previously available only to adults.
Global Innovations and Strategies in Digital Mental Health: Insights from the 6th Global Ministerial Mental Health Summit, Qatar
At the 6th Global Ministerial Mental Health Summit, eMHIC’s Prof. Anil Thapliyal highlighted how strategic investment, policy, and co-creation with lived experience can harness digital innovations to transform mental health care worldwide.
Accelerating Innovation in Digital Mental Health: Insights from the MHIN Innovation Showcase, London
The Mental Health Innovation Network’s Innovation Showcase in London spotlighted groundbreaking digital mental health solutions, with eMHIC highlighting global collaboration to accelerate innovation and real-world impact.
Upcoming Events
Webinar Replays
Member Login
Our Audience
eMHIC has and audience of 12 member countries (and growing) with thousands of subscribers around the world.
Share your thoughts
Have quality news or resources to share on the eMHIC Knowledge Bank? We’d love to consider publishing them for our global community.
